flu
COVID-19 has caused over three times more deaths than flu or pneumonia in England and Wales
October 8, 2020Medical Communications, Research and Development COVID-19, UK, flu
Newly released data has revealed that COVID-19 has resulted in many more deaths than influenza or pneumonia in England and …
New swine flu with pandemic potential identified in China
June 30, 2020Manufacturing and Production flu, flu pandemic, swine flu
A new strain of flu has emerged in pigs in China, with scientists warning it has pandemic potential. Researchers call …
New findings on influenza could help improve cancer treatments
March 20, 2020Manufacturing and Production, Medical Communications Cancer, cancer treatments, flu, flu treatments, influenza
A new study into how the body fights influenza could help improve cancer immunotherapies. Researchers at the Fox Chase Cancer …
FDA approves first adjuvanted quadrivalent flu vaccine in over-65s
February 24, 2020Sales and Marketing FDA, flu, influenza, pharma, seqirus
The FDA has just authorised its first adjuvanted quadrivalent influenza vaccine, it has been announced. Seqirus’ Fluad Quadrivalent (influenza vaccine, adjuvanted) …
FDA approves Sanofi’s quadrivalent flu vaccine for over-65s
November 6, 2019Research and Development, Sales and Marketing FDA, Fluzone, Sanofi, flu, influenza, pharma
Sanofi’s quadrivalent influenza vaccine Fluzone High Dose has secured FDA approval in adult patients over the age of 65 for …
FDA greenlights Genentech’s Xofluza for acute, uncomplicated influenza
October 18, 2019Medical Communications FDA, Genetech, Roche, US, Xofluza, flu, pharma
Roche subsidiary Genentech has announced that its polymerase acidic endonuclease inhibitor Xofluza (baloxavir marboxil) has been awarded FDA approval in …
Roche’s Xofluza reduces risk of catching flu by 86% in Phase 3 trial
September 2, 2019Research and Development, Sales and Marketing Roche, Xofluza, flu, influenza, pharma
Roche has brought forward new Phase 3 data on Xofluza (baloxavir marboxil), proving the therapy’s efficacy in the preventative treatment …
Roche’s Xofluza proves non-inferior to Tamiflu in children with flu
July 3, 2019Research and Development Roche, Tamiflu, flu, pharma
Roche has unveiled new Phase 3 data indicating that Xofluza (baloxavir marboxil) was well-tolerated and of comparable efficacy to its …
Beating the flu
February 18, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing flu, influenza, pharma, seqirus
On 14 January, the European Commission issued marketing approval for Flucelvax Tetra, the first cell-based, quadrivalent influenza vaccine. Pharmafocus spoke …
Seqirus secures first cell-based quadrivalent influenza vaccine approval in Europe
January 14, 2019Sales and Marketing Europe, Flucelvax, flu, influenza, pharma, seqirus
Seqirus has made it known that its new cell-based seasonal influenza vaccine Flucelvax Tetra has been approved by the European …
Children should be given flu vaccine to protect older people
December 21, 2018Medical Communications epidemiology, flu, health, public health, vaccines
Parents are being urged to give their children the flu vaccine in order to protect ‘older people’ from the potentially …
Probiotics have no effect on children with gastroenteritis, study shows
November 22, 2018Research and Development children, flu, gastroenteritis, probiotics, research
Despite the claims of marketing campaigns and advertisements, probiotics have no effect on gastroenteritis on children, according to a new …
Vaccine coverage falls by 6.2% since last year
October 29, 2018Sales and Marketing CDC, flu, influenza, vaccine coverage, vaccines
Despite the severity of the flu season, just 37.1% of American adults received the flu vaccine this year, according to …
First novel, single-dose flu drug approved in US in almost 20 years
October 25, 2018Sales and Marketing FDA, Shionogi, Xofluza, flu, influenza, pharma
The FDA has announced that it has approved the first single-dose flu drug with a novel mechanism of action in …
Latest content
FibroFind appoints Lee Borthwick as CEO
